1. Home
  2. HRMY vs NWN Comparison

HRMY vs NWN Comparison

Compare HRMY & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.03

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Northwest Natural Holding Company

NWN

Northwest Natural Holding Company

HOLD

Current Price

$48.85

Market Cap

2.1B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
NWN
Founded
2017
1859
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
HRMY
NWN
Price
$37.03
$48.85
Analyst Decision
Buy
Buy
Analyst Count
9
3
Target Price
$44.11
$54.33
AVG Volume (30 Days)
854.1K
293.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
3.71%
EPS Growth
7.97
36.45
EPS
0.55
2.33
Revenue
$868,453,000.00
$1,289,363,000.00
Revenue This Year
$19.75
$11.37
Revenue Next Year
$12.88
$4.46
P/E Ratio
$67.75
$21.34
Revenue Growth
21.51
11.83
52 Week Low
$25.52
$39.29
52 Week High
$40.87
$55.99

Technical Indicators

Market Signals
Indicator
HRMY
NWN
Relative Strength Index (RSI) 68.61 45.46
Support Level $35.05 $48.32
Resistance Level $39.12 $50.17
Average True Range (ATR) 1.04 1.09
MACD 0.22 0.01
Stochastic Oscillator 93.53 18.71

Price Performance

Historical Comparison
HRMY
NWN

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: